SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Prospector who wrote (241)6/12/1998 8:20:00 AM
From: macker  Read Replies (1) of 5402
 
thats why i believe that sgnc might be farther ahead than somatogen was at this point, and baxter bought them out for 9 bucks a share which was rediculously cheap considering smtg had a reserve cash burn rate of 3 million at the time.

macker
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext